Vildagliptin compared to glimepiride in combination with metformin in patients with type 2 diabetes.
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2015
At a glance
- Drugs Vildagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 17 Sep 2014 Results of a post-hoc analysis of hypoglycaemia were presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 01 Sep 2010 2-year results published in Diabetes, Obesity and Metabolism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History